“Zai Lab’s ZL-1310 Receives FDA Orphan Drug Designation for Small Cell Lung Cancer Treatment”
Zai Lab Receives FDA Orphan Drug Designation for Potential Lung Cancer Treatment Exciting News for Small Cell Lung Cancer Patients SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) has recently announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ZL-1310, a potential highly active first-in-class…